Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Valategrast is a potent and orally active dual antagonist of integrin α4β1 (VLA-4) and α4β7, with the potential for Chronic obstructive pulmonary disease (COPD) and asthma treatment.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,140.00 | |
50 mg | 6-8 weeks | $ 1,490.00 | |
100 mg | 6-8 weeks | $ 2,440.00 |
Description | Valategrast is a potent and orally active dual antagonist of integrin α4β1 (VLA-4) and α4β7, with the potential for Chronic obstructive pulmonary disease (COPD) and asthma treatment. |
In vitro | Valategrast contains a common L-phenylalanine-N-aroyl group in which carboxylic acids are responsible for metal ion binding in metal ion-associated adhesion sites (MIDAS)[2]. |
Synonyms | R-411 free base |
Molecular Weight | 604.95 |
Formula | C30H32Cl3N3O4 |
CAS No. | 220847-86-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Valategrast 220847-86-9 Others R-411 free base R411 R 411 R-411 inhibitor inhibit